Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using ¹⁸F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549.
Journal Information
Full Title: Ann Nucl Med
Abbreviation: Ann Nucl Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nuclear Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest All authors are employees of the Takeda Pharmaceutical Company Limited, and the present work was supported wholly by this entity."
"Conflict of interestAll authors are employees of the Takeda Pharmaceutical Company Limited, and the present work was supported wholly by this entity."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025